• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Meet 5 companies developing novel drug-delivery devices

October 26, 2017 By Sarah Faulkner

BD's Libertas wearable injectorJanice Adkins, Becton Dickinson‘s (NYSE: BDX) associate director of marketing, told the audience at PODD this year that the company is focusing its development efforts around trends relating to the delivery of complex biologics.

She pointed towards the company’s Libertas wearable injector as an example of a device that has been designed to address patient needs and the needs of BD’s pharmaceutical partners.

“We are all seeing the need or the desire to move injection of biologics from your standard or traditional healthcare setting to home care delivery settings,” Adkins said. “That is also driving the transformation or the shift of injection of drugs or infusion of drugs from intravenous infusion to subcutaneous delivery.”

BD’s Libertas wearable injector is a pre-filled, disposable, single-use technology that can deliver up to 10 mL of drugs, Adkins explained.

The primary container used with the company’s Libertas product is the Neopak refill syringe, which Adkins said is specifically designed for sensitive biologics.

The wearable also features BD’s Penta Point needle technology, which helps ease the injection into the skin and lower injection pressure, according to Adkins.

“Ultimately what you get is a fully integrated system with a primary container with a secondary device that does work optimally as a system, that would meet the combination requirements and would also lower your risk in the market place,” she said.

The company has a number of other products designed for biologics with different properties, like its Physioject auto-injector which was designed for small-volume 1 mL injections. BD also highlighted its Intevia product, which it’s developing for the delivery of viscous drugs in 1 mL injections.

Next >>

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6

Filed Under: Auto-injectors, Clinical Trials, Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development, Wall Street Beat Tagged With: Becton Dickinson, Bespak, Enable Injections, Insulet, Pfizer Inc., West Pharmaceutical Services

IN CASE YOU MISSED IT

  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development
  • Ypsomed brings autoinjector for dual GCG/GLP-1 delivery to China
  • Convatec wins FDA approval for Parkinson’s treatment infusion tech

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS